Kumpulan Info tentang,
UNIVERSITAS SURABAYA
| No | Source Title | CiteScore | Quartile | Publisher | Highest percentile | Citations 2021-24 | Documents 2021-24 |
|---|---|---|---|---|---|---|---|
| 10471 | American Journal of Cardiovascular Drugs | 5.4 | Q2 | Springer Nature | 73.0% 107/397 Cardiology and Cardiovascular Medicine | 1249 | 233 |
| 10472 | Recent Patents on Anti-Cancer Drug Discovery | 5.6 | Q2 | Bentham Science Publishers | 72.0% 77/275 Pharmacology (medical) | 823 | 146 |
| 10473 | Cancer Chemotherapy and Pharmacology | 5.7 | Q2 | Springer Nature | 72.0% 76/275 Pharmacology (medical) | 2889 | 508 |
| 10474 | Pharmaceutical Statistics | 3.2 | Q2 | John Wiley & Sons | 71.0% 85/293 Statistics and Probability | 1045 | 330 |
| 10475 | Drug Metabolism and Pharmacokinetics | 5.6 | Q2 | Japanese Society for the Study of Xenobiotics | 71.0% 79/275 Pharmacology (medical) | 1014 | 182 |
| 10476 | Clinical Therapeutics | 5.6 | Q2 | Elsevier | 71.0% 78/275 Pharmacology (medical) | 3560 | 638 |
| 10477 | Journal of Addiction Medicine | 5.4 | Q2 | Wolters Kluwer Health | 71.0% 166/580 Psychiatry and Mental Health | 3241 | 598 |
| 10478 | European Journal of Clinical Pharmacology | 5.5 | Q2 | Springer Nature | 70.0% 81/275 Pharmacology (medical) | 3699 | 673 |
| 10479 | Current Reviews in Clinical and Experimental Pharmacology | 3.5 | Q2 | Bentham Science Publishers | 70.0% 23/77 General Pharmacology, Toxicology and Pharmaceutics | 359 | 102 |
| 10480 | Pharmaceutical Medicine | 5.5 | Q2 | Springer Nature | 69.0% 84/275 Pharmacology (medical) | 714 | 131 |
| 10481 | JACCP Journal of the American College of Clinical Pharmacy | 2.6 | Q2 | John Wiley & Sons | 69.0% 15/47 Pharmacy | 1378 | 522 |
| 10482 | Clinical Drug Investigation | 5.4 | Q2 | Springer Nature | 68.0% 86/275 Pharmacology (medical) | 1874 | 347 |
| 10483 | Journal of Child and Adolescent Psychopharmacology | 3.5 | Q2 | Mary Ann Liebert | 68.0% 109/342 Pediatrics, Perinatology and Child Health | 806 | 233 |
| 10484 | Experimental and Clinical Psychopharmacology | 5 | Q2 | American Psychological Association | 67.0% 190/580 Psychiatry and Mental Health | 1838 | 369 |
| 10485 | Fundamental and Clinical Pharmacology | 5.3 | Q2 | John Wiley & Sons | 66.0% 94/275 Pharmacology (medical) | 2050 | 390 |
| 10486 | Journal of Acquired Immune Deficiency Syndromes (1999) | 5.3 | Q2 | Wolters Kluwer Health | 66.0% 93/275 Pharmacology (medical) | 4936 | 933 |
| 10487 | Expert Opinion on Drug Safety | 5.1 | Q2 | Taylor & Francis | 65.0% 96/275 Pharmacology (medical) | 2723 | 532 |
| 10488 | Expert Review of Anticancer Therapy | 5.2 | Q2 | Taylor & Francis | 65.0% 95/275 Pharmacology (medical) | 2366 | 453 |
| 10489 | Journal of Clinical Pharmacology | 5.1 | Q2 | John Wiley & Sons | 64.0% 98/275 Pharmacology (medical) | 3261 | 641 |
| 10490 | Primary Care - Clinics in Office Practice | 5.1 | Q2 | Elsevier | 64.0% 97/275 Pharmacology (medical) | 1020 | 200 |
| 10491 | Journal of Ocular Pharmacology and Therapeutics | 3.5 | Q2 | Mary Ann Liebert | 63.0% 52/141 Ophthalmology | 1036 | 295 |
| 10492 | International Clinical Psychopharmacology | 4.6 | Q2 | Wolters Kluwer Health | 63.0% 210/580 Psychiatry and Mental Health | 836 | 181 |
| 10493 | Expert Review of Pharmacoeconomics and Outcomes Research | 3.8 | Q2 | Taylor & Francis | 62.0% 120/320 Health Policy | 1626 | 431 |
| 10494 | Expert Opinion on Emerging Drugs | 4.7 | Q2 | Taylor & Francis | 62.0% 105/275 Pharmacology (medical) | 545 | 115 |
| 10495 | Journal of Clinical Pharmacy and Therapeutics | 4.8 | Q2 | John Wiley & Sons | 62.0% 104/275 Pharmacology (medical) | 2796 | 586 |
| 10496 | Journal of Clinical Psychopharmacology | 4.3 | Q2 | Wolters Kluwer Health | 61.0% 225/580 Psychiatry and Mental Health | 1253 | 290 |
| 10497 | Therapeutic Drug Monitoring | 4.7 | Q2 | Wolters Kluwer Health | 61.0% 106/275 Pharmacology (medical) | 1849 | 391 |
| 10498 | European Journal of Contraception and Reproductive Health Care | 3.7 | Q2 | Taylor & Francis | 60.0% 83/210 Obstetrics and Gynecology | 813 | 222 |
| 10499 | Clinical Psychopharmacology and Neuroscience | 4.3 | Q2 | Korean College of Neuropsychopharmacology | 60.0% 228/580 Psychiatry and Mental Health | 1303 | 303 |
| 10500 | PharmaNutrition | 4.2 | Q2 | Elsevier | 60.0% 159/404 Food Science | 516 | 123 |